Total Payments
$747.93
2023 Payments
$19.26
Companies
6
Transactions
11
Medicare Patients
9,266
Medicare Billing
$343,279
Payment Breakdown by Category
Food & Beverage$705.37 (94.3%)
Education$42.56 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $705.37 | 8 | 94.3% |
| Education | $42.56 | 3 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $365.17 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $224.91 | 4 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $103.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $21.70 | 1 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $19.26 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $13.89 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.26 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($19.26) |
| 2022 | $35.59 | 2 | Merck Sharp & Dohme LLC ($21.70) |
| 2018 | $125.00 | 1 | Novartis Pharmaceuticals Corporation ($125.00) |
| 2017 | $568.08 | 7 | Novartis Pharmaceuticals Corporation ($240.17) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/30/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $137.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $109.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $103.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/10/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/09/2017 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $6.97 | General |
| 03/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $105.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $103.00 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,276 | 2,922 | $237,316 | $73,660 |
| 2022 | 14 | 2,278 | 2,978 | $255,790 | $80,411 |
| 2021 | 15 | 2,622 | 3,378 | $323,132 | $106,097 |
| 2020 | 15 | 2,090 | 2,627 | $270,825 | $83,112 |
Total Patients
9,266
Total Services
11,905
Medicare Billing
$343,279
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 329 | $83,990 | $29,677 | 35.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,482 | 2,036 | $46,383 | $12,772 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 58 | $19,913 | $8,010 | 40.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 51 | $23,237 | $7,089 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 70 | $12,804 | $4,452 | 34.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $20,930 | $3,801 | 18.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 223 | 233 | $12,727 | $2,447 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,814 | $2,259 | 38.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 24 | 24 | $4,609 | $1,562 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,427 | $631.40 | 26.0% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 20 | 20 | $1,425 | $348.12 | 24.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 25 | 25 | $1,758 | $338.56 | 19.3% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 12 | 12 | $843.00 | $161.92 | 19.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 20 | 21 | $456.00 | $111.01 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 342 | $86,388 | $30,673 | 35.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,425 | 1,947 | $46,728 | $12,419 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 67 | 81 | $27,621 | $11,185 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $16,632 | $5,783 | 34.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 74 | $12,432 | $4,268 | 34.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 43 | $10,234 | $3,498 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 255 | 290 | $17,110 | $3,127 | 18.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 11 | 12 | $15,444 | $2,886 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 42 | $7,059 | $2,126 | 30.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 26 | $4,576 | $1,518 | 33.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $4,256 | $1,087 | 25.5% |
About Dr. Christopher Luttmann, MD
Dr. Christopher Luttmann, MD is a Cardiovascular Disease healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891834958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Luttmann, MD has received a total of $747.93 in payments from pharmaceutical and medical device companies, with $19.26 received in 2023. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($705.37).
As a Medicare-enrolled provider, Luttmann has provided services to 9,266 Medicare beneficiaries, totaling 11,905 services with total Medicare billing of $343,279. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Pawtucket, RI
- Active Since 02/05/2007
- Last Updated 02/12/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1891834958
Products in Payments
- ENTRESTO (Drug) $365.17
- XARELTO (Drug) $217.94
- ELIQUIS (Drug) $103.00
- VERQUVO (Drug) $21.70
- LifeVest (Device) $19.26
- FARXIGA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pawtucket
Andrew Hordes, Md, MD
Cardiovascular Disease — Payments: $11,049
Cardiovascular Disease $11,049
Thomas Noonan, Md, MD
Cardiovascular Disease — Payments: $817.57
Cardiovascular Disease $817.57
Lauralyn Cannistra, Md, MD
Cardiovascular Disease — Payments: $262.20
Cardiovascular Disease $262.20
Dr. Suhdong Hahn, Md, MD
Cardiovascular Disease — Payments: $119.96
Cardiovascular Disease $119.96
Dr. Andrew Nowak, Md, MD
Cardiovascular Disease — Payments: $53.89
Cardiovascular Disease $53.89
Anthony Cannistra, Md, MD
Cardiovascular Disease
Cardiovascular Disease